236 related articles for article (PubMed ID: 20197055)
1. Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation.
Sopasakis VR; Liu P; Suzuki R; Kondo T; Winnay J; Tran TT; Asano T; Smyth G; Sajan MP; Farese RV; Kahn CR; Zhao JJ
Cell Metab; 2010 Mar; 11(3):220-30. PubMed ID: 20197055
[TBL] [Abstract][Full Text] [Related]
2. Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons.
Al-Qassab H; Smith MA; Irvine EE; Guillermet-Guibert J; Claret M; Choudhury AI; Selman C; Piipari K; Clements M; Lingard S; Chandarana K; Bell JD; Barsh GS; Smith AJ; Batterham RL; Ashford ML; Vanhaesebroeck B; Withers DJ
Cell Metab; 2009 Nov; 10(5):343-54. PubMed ID: 19883613
[TBL] [Abstract][Full Text] [Related]
3. Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.
Liu W; Cao H; Ye C; Chang C; Lu M; Jing Y; Zhang D; Yao X; Duan Z; Xia H; Wang YC; Jiang J; Liu MF; Yan J; Ying H
Nat Commun; 2014 Dec; 5():5684. PubMed ID: 25471065
[TBL] [Abstract][Full Text] [Related]
4. Phosphoinositide 3-kinases p110α and p110β have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming.
Blair TA; Moore SF; Williams CM; Poole AW; Vanhaesebroeck B; Hers I
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1681-8. PubMed ID: 24903091
[TBL] [Abstract][Full Text] [Related]
5. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.
Foukas LC; Claret M; Pearce W; Okkenhaug K; Meek S; Peskett E; Sancho S; Smith AJ; Withers DJ; Vanhaesebroeck B
Nature; 2006 May; 441(7091):366-70. PubMed ID: 16625210
[TBL] [Abstract][Full Text] [Related]
6. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis.
Jia S; Liu Z; Zhang S; Liu P; Zhang L; Lee SH; Zhang J; Signoretti S; Loda M; Roberts TM; Zhao JJ
Nature; 2008 Aug; 454(7205):776-9. PubMed ID: 18594509
[TBL] [Abstract][Full Text] [Related]
7. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta.
Taniguchi CM; Kondo T; Sajan M; Luo J; Bronson R; Asano T; Farese R; Cantley LC; Kahn CR
Cell Metab; 2006 May; 3(5):343-53. PubMed ID: 16679292
[TBL] [Abstract][Full Text] [Related]
8. Both p110alpha and p110beta isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus.
Tups A; Anderson GM; Rizwan M; Augustine RA; Chaussade C; Shepherd PR; Grattan DR
J Neuroendocrinol; 2010 Jun; 22(6):534-42. PubMed ID: 20236230
[TBL] [Abstract][Full Text] [Related]
9. Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling.
Zhang B; Luk C; Valadares J; Aronis C; Foukas LC
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884613
[TBL] [Abstract][Full Text] [Related]
10. The Phosphoinosotide 3-Kinase Catalytic Subunit p110α is Required for Normal Lens Growth.
Sellitto C; Li L; Vaghefi E; Donaldson PJ; Lin RZ; White TW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3145-51. PubMed ID: 27304846
[TBL] [Abstract][Full Text] [Related]
11. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling.
Chaussade C; Rewcastle GW; Kendall JD; Denny WA; Cho K; Grønning LM; Chong ML; Anagnostou SH; Jackson SP; Daniele N; Shepherd PR
Biochem J; 2007 Jun; 404(3):449-58. PubMed ID: 17362206
[TBL] [Abstract][Full Text] [Related]
12. Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.
Kuang JR; Zhang ZH; Leng WL; Lei XT; Liang ZW
Mol Cell Endocrinol; 2017 May; 447():106-115. PubMed ID: 28237722
[TBL] [Abstract][Full Text] [Related]
13. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
14. p110α Hot Spot Mutations E545K and H1047R Exert Metabolic Reprogramming Independently of p110α Kinase Activity.
Chaudhari A; Krumlinde D; Lundqvist A; Akyürek LM; Bandaru S; Skålén K; Ståhlman M; Borén J; Wettergren Y; Ejeskär K; Rotter Sopasakis V
Mol Cell Biol; 2015 Oct; 35(19):3258-73. PubMed ID: 26169833
[TBL] [Abstract][Full Text] [Related]
15. PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers.
Wang Q; Liu P; Spangle JM; Von T; Roberts TM; Lin NU; Krop IE; Winer EP; Zhao JJ
Oncogene; 2016 Jul; 35(27):3607-12. PubMed ID: 26500061
[TBL] [Abstract][Full Text] [Related]
16. Hepatic deletion of p110α and p85α results in insulin resistance despite sustained IRS1-associated phosphatidylinositol kinase activity.
Chaudhari A; Ejeskär K; Wettergren Y; Kahn CR; Rotter Sopasakis V
F1000Res; 2017; 6():1600. PubMed ID: 29983910
[No Abstract] [Full Text] [Related]
17. Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Liao YJ; Lee TS; Twu YC; Hsu SM; Yang CP; Wang CK; Liang YC; Chen YA
J Biomed Sci; 2016 Oct; 23(1):69. PubMed ID: 27716281
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.
Brachmann SM; Ueki K; Engelman JA; Kahn RC; Cantley LC
Mol Cell Biol; 2005 Mar; 25(5):1596-607. PubMed ID: 15713620
[TBL] [Abstract][Full Text] [Related]
19. PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling.
Braccini L; Ciraolo E; Campa CC; Perino A; Longo DL; Tibolla G; Pregnolato M; Cao Y; Tassone B; Damilano F; Laffargue M; Calautti E; Falasca M; Norata GD; Backer JM; Hirsch E
Nat Commun; 2015 Jun; 6():7400. PubMed ID: 26100075
[TBL] [Abstract][Full Text] [Related]
20. Distinct and opposing roles for the phosphatidylinositol 3-OH kinase catalytic subunits p110α and p110β in the regulation of insulin secretion from rodent and human beta cells.
Kolic J; Spigelman AF; Plummer G; Leung E; Hajmrle C; Kin T; Shapiro AM; Manning Fox JE; MacDonald PE
Diabetologia; 2013 Jun; 56(6):1339-49. PubMed ID: 23568272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
